STOCK TITAN

[SCHEDULE 13G/A] Prothena Corporation plc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Todd W. Fennell filed an amendment to a Schedule 13G disclosing beneficial ownership of 4,350,846 ordinary shares of Prothena Corporation plc, representing approximately 8.08% of the 53,826,982 shares outstanding. The reported holdings consist of 40,000 shares held by an irrevocable gift trust and 4,310,846 shares held by multiple grantor retained annuity trusts, for which Mr. Fennell serves as independent trustee.

The filing shows shared voting and shared dispositive power over all reported shares and includes a certification that the securities are not held to change or influence control of the issuer. This disclosure provides investors a clear view of a materially significant, statedly passive stake in PRTA and identifies the legal vehicles through which the interest is held.

Todd W. Fennell ha depositato un emendamento alla Schedule 13G rivelando la titolarità effettiva di 4.350.846 azioni ordinarie di Prothena Corporation plc, pari a circa il 8,08% delle 53.826.982 azioni in circolazione. La partecipazione dichiarata comprende 40.000 azioni detenute da un trust irrevocabile per donazioni e 4.310.846 azioni detenute da più grantor retained annuity trusts (GRAT), per i quali il sig. Fennell agisce come trustee indipendente.

La comunicazione indica il possesso di poteri di voto condivisi e di poteri di disposizione condivisi su tutte le azioni riportate e include una certificazione che i titoli non sono detenuti per modificare o influenzare il controllo dell'emittente. Questa divulgazione offre agli investitori una visione chiara di una partecipazione materialmente rilevante dichiaratamente passiva in PRTA e identifica i veicoli legali attraverso cui tale interesse è detenuto.

Todd W. Fennell presentó una enmienda a una Schedule 13G revelando la titularidad beneficiaria de 4.350.846 acciones ordinarias de Prothena Corporation plc, que representan aproximadamente el 8,08% de las 53.826.982 acciones en circulación. Las participaciones declaradas consisten en 40.000 acciones mantenidas por un fideicomiso irrevocable de donación y 4.310.846 acciones mantenidas por varios grantor retained annuity trusts (GRAT), de los que el Sr. Fennell actúa como fiduciario independiente.

La presentación indica poderes de voto compartidos y poderes de disposición compartidos sobre todas las acciones informadas e incluye una certificación de que los valores no se mantienen con la intención de cambiar o influir en el control del emisor. Esta revelación proporciona a los inversores una visión clara de una participación materialmente significativa declarada como pasiva en PRTA e identifica los vehículos legales a través de los cuales se mantiene el interés.

Todd W. Fennell은 Schedule 13G 수정보고서를 제출하여 Prothena Corporation plc의 4,350,846주 보통주에 대한 실질적 소유를 공개했으며, 이는 유통주식수 53,826,982주의 약 8.08%에 해당합니다. 보고된 보유는 취소 불가능한 증여 신탁이 보유한 40,000주와 여러 개의 창립자 유지 연금 신탁(grantor retained annuity trusts, GRATs)이 보유한 4,310,846주로 구성되어 있으며, Fennell 씨는 이들 신탁의 독립 수탁자입니다.

신고서는 보고된 모든 주식에 대해 공동 의결권 및 공동 처분권이 있음을 표시하고 있으며, 해당 증권이 발행자의 지배권을 변경하거나 영향력을 행사하려는 목적으로 보유된 것이 아님을 인증하고 있습니다. 이 공개는 투자자에게 PRTA에 대한 실질적으로 중요한, 명시적으로 수동적인 지분을 명확히 보여주고 해당 지분이 보유된 법적 수단을 식별해 줍니다.

Todd W. Fennell a déposé un amendement à une Schedule 13G révélant la détention bénéficiaire de 4 350 846 actions ordinaires de Prothena Corporation plc, représentant environ 8,08 % des 53 826 982 actions en circulation. Les participations déclarées se composent de 40 000 actions détenues par une fiducie irrévocable de donation et de 4 310 846 actions détenues par plusieurs grantor retained annuity trusts (GRATs), pour lesquels M. Fennell exerce la fonction de fiduciaire indépendant.

Le dépôt indique pour toutes les actions déclarées un pouvoir de vote partagé et un pouvoir discrétionnaire partagé et comprend une attestation précisant que ces titres ne sont pas détenus dans le but de modifier ou d'influencer le contrôle de l'émetteur. Cette divulgation donne aux investisseurs une vision claire d'une participation matériellement significative, déclarée comme passive, dans PRTA et identifie les véhicules juridiques par lesquels cet intérêt est détenu.

Todd W. Fennell reichte eine Änderung zu einer Schedule 13G ein und gab dabei den wirtschaftlichen Besitz von 4.350.846 Stammaktien der Prothena Corporation plc bekannt, was etwa 8,08% der 53.826.982 ausstehenden Aktien entspricht. Die gemeldeten Bestände setzen sich zusammen aus 40.000 Aktien, die von einem unwiderruflichen Geschenk-Trust gehalten werden, und 4.310.846 Aktien, die von mehreren grantor retained annuity trusts (GRATs) gehalten werden, für die Herr Fennell als unabhängiger Treuhänder fungiert.

Die Einreichung weist für alle gemeldeten Aktien gemeinsame Stimm- und Verfügungsrechte aus und enthält eine Bescheinigung, dass die Wertpapiere nicht gehalten werden, um die Kontrolle des Emittenten zu ändern oder zu beeinflussen. Diese Offenlegung verschafft Anlegern einen klaren Überblick über eine materiell bedeutende, ausdrücklich passive Beteiligung an PRTA und benennt die rechtlichen Vehikel, über die das Interesse gehalten wird.

Positive
  • Material disclosure of a significant 8.08% stake (4,350,846 shares) in Prothena enhances market transparency
  • Clear identification of ownership vehicles: 40,000 shares in an irrevocable gift trust and 4,310,846 shares in grantor retained annuity trusts
  • Filing includes an explicit certification that the shares are not held to change or influence control, indicating a stated passive intent
Negative
  • None.

Insights

Passive 8.08% stake disclosed; material in size but filed as non-control, so immediate market impact is likely limited.

The filing reports 4,350,846 shares (≈8.08% of 53,826,982 outstanding). From a capital-markets perspective, stakes above 5% attract attention because they can influence liquidity and perceptions of insider alignment, but this Schedule 13G/A includes a certification that the holdings are not intended to influence control, indicating a passive position. The shares are held through trusts with shared voting/dispositive powers, which can affect how quickly the position could be mobilized if intentions changed.

Disclosure enhances governance transparency; shared trustee roles warrant monitoring but filing signals no control attempt.

The report itemizes ownership through an irrevocable gift trust (40,000 shares) and multiple grantor retained annuity trusts (4,310,846 shares) with the reporting person acting as independent trustee. That structure gives shared voting and dispositive power, which is important for understanding who can exercise influence in practice. The explicit certification that the position is not held to affect control reduces immediate governance concerns, though investors should note the legal vehicles and power allocations disclosed.

Todd W. Fennell ha depositato un emendamento alla Schedule 13G rivelando la titolarità effettiva di 4.350.846 azioni ordinarie di Prothena Corporation plc, pari a circa il 8,08% delle 53.826.982 azioni in circolazione. La partecipazione dichiarata comprende 40.000 azioni detenute da un trust irrevocabile per donazioni e 4.310.846 azioni detenute da più grantor retained annuity trusts (GRAT), per i quali il sig. Fennell agisce come trustee indipendente.

La comunicazione indica il possesso di poteri di voto condivisi e di poteri di disposizione condivisi su tutte le azioni riportate e include una certificazione che i titoli non sono detenuti per modificare o influenzare il controllo dell'emittente. Questa divulgazione offre agli investitori una visione chiara di una partecipazione materialmente rilevante dichiaratamente passiva in PRTA e identifica i veicoli legali attraverso cui tale interesse è detenuto.

Todd W. Fennell presentó una enmienda a una Schedule 13G revelando la titularidad beneficiaria de 4.350.846 acciones ordinarias de Prothena Corporation plc, que representan aproximadamente el 8,08% de las 53.826.982 acciones en circulación. Las participaciones declaradas consisten en 40.000 acciones mantenidas por un fideicomiso irrevocable de donación y 4.310.846 acciones mantenidas por varios grantor retained annuity trusts (GRAT), de los que el Sr. Fennell actúa como fiduciario independiente.

La presentación indica poderes de voto compartidos y poderes de disposición compartidos sobre todas las acciones informadas e incluye una certificación de que los valores no se mantienen con la intención de cambiar o influir en el control del emisor. Esta revelación proporciona a los inversores una visión clara de una participación materialmente significativa declarada como pasiva en PRTA e identifica los vehículos legales a través de los cuales se mantiene el interés.

Todd W. Fennell은 Schedule 13G 수정보고서를 제출하여 Prothena Corporation plc의 4,350,846주 보통주에 대한 실질적 소유를 공개했으며, 이는 유통주식수 53,826,982주의 약 8.08%에 해당합니다. 보고된 보유는 취소 불가능한 증여 신탁이 보유한 40,000주와 여러 개의 창립자 유지 연금 신탁(grantor retained annuity trusts, GRATs)이 보유한 4,310,846주로 구성되어 있으며, Fennell 씨는 이들 신탁의 독립 수탁자입니다.

신고서는 보고된 모든 주식에 대해 공동 의결권 및 공동 처분권이 있음을 표시하고 있으며, 해당 증권이 발행자의 지배권을 변경하거나 영향력을 행사하려는 목적으로 보유된 것이 아님을 인증하고 있습니다. 이 공개는 투자자에게 PRTA에 대한 실질적으로 중요한, 명시적으로 수동적인 지분을 명확히 보여주고 해당 지분이 보유된 법적 수단을 식별해 줍니다.

Todd W. Fennell a déposé un amendement à une Schedule 13G révélant la détention bénéficiaire de 4 350 846 actions ordinaires de Prothena Corporation plc, représentant environ 8,08 % des 53 826 982 actions en circulation. Les participations déclarées se composent de 40 000 actions détenues par une fiducie irrévocable de donation et de 4 310 846 actions détenues par plusieurs grantor retained annuity trusts (GRATs), pour lesquels M. Fennell exerce la fonction de fiduciaire indépendant.

Le dépôt indique pour toutes les actions déclarées un pouvoir de vote partagé et un pouvoir discrétionnaire partagé et comprend une attestation précisant que ces titres ne sont pas détenus dans le but de modifier ou d'influencer le contrôle de l'émetteur. Cette divulgation donne aux investisseurs une vision claire d'une participation matériellement significative, déclarée comme passive, dans PRTA et identifie les véhicules juridiques par lesquels cet intérêt est détenu.

Todd W. Fennell reichte eine Änderung zu einer Schedule 13G ein und gab dabei den wirtschaftlichen Besitz von 4.350.846 Stammaktien der Prothena Corporation plc bekannt, was etwa 8,08% der 53.826.982 ausstehenden Aktien entspricht. Die gemeldeten Bestände setzen sich zusammen aus 40.000 Aktien, die von einem unwiderruflichen Geschenk-Trust gehalten werden, und 4.310.846 Aktien, die von mehreren grantor retained annuity trusts (GRATs) gehalten werden, für die Herr Fennell als unabhängiger Treuhänder fungiert.

Die Einreichung weist für alle gemeldeten Aktien gemeinsame Stimm- und Verfügungsrechte aus und enthält eine Bescheinigung, dass die Wertpapiere nicht gehalten werden, um die Kontrolle des Emittenten zu ändern oder zu beeinflussen. Diese Offenlegung verschafft Anlegern einen klaren Überblick über eine materiell bedeutende, ausdrücklich passive Beteiligung an PRTA und benennt die rechtlichen Vehikel, über die das Interesse gehalten wird.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G



Fennell Todd W.
Signature:/s/ Diana L. Hayes
Name/Title:attorney-in-fact
Date:08/13/2025

Comments accompanying signature: Pursuant to a limited power of attorney dated as of February 8, 2024, a copy of which is on file with the Commission.

FAQ

How many Prothena (PRTA) shares does Todd W. Fennell beneficially own?

The filing reports 4,350,846 ordinary shares beneficially owned by Todd W. Fennell, representing approximately 8.08% of outstanding shares.

Through what vehicles are Fennell's PRTA shares held?

The shares are held via an irrevocable gift trust (40,000 shares) and multiple grantor retained annuity trusts (4,310,846 shares); Mr. Fennell serves as independent trustee.

Does Todd W. Fennell have sole voting or dispositive power over these shares?

No. The filing states 0 sole voting power and 0 sole dispositive power, and reports 4,350,846 shares of shared voting and shared dispositive power.

Is the disclosed position intended to influence control of Prothena (PRTA)?

The certification in the filing states the securities were not acquired and are not held to change or influence control of the issuer.

What form was filed and what event date is associated with the filing?

A Schedule 13G/A (Amendment No. 4) was filed in relation to the event date 06/30/2025.
Prothena

NASDAQ:PRTA

PRTA Rankings

PRTA Latest News

PRTA Latest SEC Filings

PRTA Stock Data

405.88M
42.97M
19.58%
74.3%
8.84%
Biotechnology
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2